江苏吴中医药发展股份有限公司 关于公司股票可能存在因股价低于1元而终止上市的风险提示公告

Group 1 - The company's stock closed at 0.98 CNY per share on November 7, 2025, which is below the 1 CNY threshold, potentially leading to delisting if it remains below this price for 20 consecutive trading days [2][5] - The company received an administrative penalty notice from the China Securities Regulatory Commission on July 13, 2025, indicating that it inflated revenue, costs, and profits, with false records in annual reports from 2020 to 2023 [5][6] - The company is subject to a risk warning for delisting due to significant violations, as per the Shanghai Stock Exchange regulations, and has been under a delisting risk warning since July 14, 2025 [5][4] Group 2 - According to the Shanghai Stock Exchange rules, if a company's stock price falls below 1 CNY for 20 consecutive trading days, it may face termination of listing [2][3] - The company is required to disclose risk warning announcements if its stock price falls below 1 CNY, with specific disclosure requirements based on the duration of the price drop [3][4] - The company has designated information disclosure media, including the China Securities Journal and the Shanghai Securities Journal, for communicating relevant information to investors [5][6]